PS
Pradip Santukrao Khomane
About Pradip Santukrao Khomane
Data last updated:
Pradip Santukrao Khomane has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Curegenix Pharma Private Limited and Manyad Valley Agrotech & Export Farmers Producer Company Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curegenix Pharma Private Limited U21000MH2024PTC433923 | Director | 21 Oct 2024 | 2024 | – | Active |
| Manyad Valley Agrotech & Export Farmers Producer Company Limited U01100MH2022PTC388540 | Director | 12 Aug 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradip Santukrao Khomane
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradip Santukrao Khomane
Pradip Santukrao Khomane has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Curegenix Pharma Private Limited and Manyad Valley Agrotech & Export Farmers Producer Company Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Pradip Santukrao Khomane is associated with 2 companies as Director, including Curegenix Pharma Private Limited, Manyad Valley Agrotech & Export Farmers Producer Company Limited.
Pradip Santukrao Khomane has expertise in General Business, Technology.
Pradip Santukrao Khomane has 4 years in corporate governance.
Pradip Santukrao Khomane currently holds positions at 2 companies: Curegenix Pharma Private Limited, Manyad Valley Agrotech & Export Farmers Producer Company Limited.